Puma Biotechnology, Inc. PBYI
NASDAQ · United States · Health Technology
$9.84-0.09 (-0.91%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 0.16 | 0.04 | +300.0% | $56.50M | +6.6% | +11.5%$7.99→$8.91 |
| Q1 2026 | 2026-05-07 | -0.07 | -0.17 | +58.8% | — | — | +0.5%$7.45→$7.49 |
| Q4 2025 | 2026-02-26 | 0.26 | 0.19 | +36.8% | — | — | -25.8%$7.68→$5.70 |
| Q3 2025 | 2025-11-06 | 0.17 | 0.07 | +142.9% | — | — | +21.0%$4.95→$5.99 |
| Q4 2023 | 2024-02-29 | 0.31 | 0.37 | -16.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.